Improving PKU Management
Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE® in the Middle East
Jun 2023.jpg)
.jpg)
Sep 2023 IMPROVING AVAILABILITY OF ORPHAN DRUGS IN SAUDI ARABIA The Saudi Food and Drug Authority has recently issued new guidelines for orphan drug designation, with a positive impact on companies and patients.
Read more
Nov 2023 Certificate of Recognition We are overjoyed with this remarkable achievement, especially since it is rigorously judged by a panel of international business experts.
Read more